Darren G. Woodside, PhD

Darren Woodside, Ph.D., is the Vice President for Research and Director of the Flow Cytometry and Imaging Core at the Texas Heart Institute. Show full bio

Dr. Woodside’s research centers around the role that cell adhesion plays in cardiovascular and autoimmune diseases, and the development of novel means to identify and treat these diseases. Prior to assuming the position of Vice President, he served as Associate Director of the Molecular Cardiology Research Laboratories at THI and Associate Director of Drug Discovery at Encysive Pharmaceuticals. He was awarded his Ph.D. from the University of Texas MD Anderson Cancer Center’s Department of Immunology and was a post-doctoral fellow at The Scripps Research Institute.

He has authored numerous publications, served on Editorial Review Boards, and currently chairs the NIH Innovative Immunology Study Section.

See Publications

Texas Heart Institute Positions


  • Undergraduate:

    Queen's University at Kingston

  • Postgraduate:

    University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences

  • Fellowships:

    The Scripps Research Institute


Pogostin, B. H., Yu, M. H., Azares, A. R. et al. (2022). Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity. Biomater Sci. https://doi.org/10.1039/d2bm01242a.
Hickman, A., Koetsier, J., Kurtanich, T. et al. (2022). LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest 132, e154152. https://doi.org/10.1172/JCI154152.
Lokugamage, N., Chowdhury, I. H., Biediger, R. J. et al. (2021). Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. NPJ Vaccines 6, 114. https://doi.org/10.1038/s41541-021-00378-5.
Lopez-Silva, T. L., Leach, D. G., Azares, A. et al. (2020). Chemical functionality of multidomain peptide hydrogels governs early host immune response. Biomaterials 231, 119667. https://doi.org/10.1016/j.biomaterials.2019.119667.
Bakthavatsalam, D., Craft, J. W., Kazansky, A. et al. (2020). Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk. Front Immunol 11, 575085. https://doi.org/10.3389/fimmu.2020.575085.
Woodside, D. G. (2019). Nanoparticle imaging of vascular inflammation and remodeling in atherosclerotic disease. Current Cardiovascular Imaging Reports 12. https://doi.org/10.1007/s12410-019-9501-9.
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B. et al. (2018). Magnetic resonance imaging of atherosclerotic plaque at clinically relevant field strengths (1T) by targeting the integrin α4β1. Sci Rep 8, 3733. https://doi.org/10.1038/s41598-018-21893-x.
Kumar, V. A., Liu, Q., Wickremasinghe, N. C. et al. (2016). Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials 98, 113–119. https://doi.org/10.1016/j.biomaterials.2016.04.032.
Deng, Y., Yang, Z., Terry, T. et al. (2016). Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia. Nat Commun 7, 11276. https://doi.org/10.1038/ncomms11276.
Bakthavatsalam, D., Soung, R. H., Tweardy, D. J. et al. (2014). Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor. FEBS Lett 588, 2133–2140. https://doi.org/10.1016/j.febslet.2014.04.049.

Recent News

The Texas Heart Institute Research Symposium: Cutting-Edge Innovations Driving Translational Clinical Care

HOUSTON (Oct. 27, 2023) — Renowned scientists and clinicians from The Texas Heart Institute gathered this week for its inspiring,...

Houston Supports The Texas Heart Institute in Style at The Post Oak

The Supper Club gala, held at the fabulous Post Oak Hotel, was a magical night about giving back and raising...

The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug

HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was...